Celldex Therapeutics Inc. (CLDX)
NASDAQ · Healthcare
Celldex Therapeutics Inc. Shares Outstanding 2020–2025
Celldex Therapeutics Inc. annual/quarterly shares outstanding history and growth rate from 2020 to 2026. Shares outstanding refers to a company's stock currently held by all its shareholders, including institutional investors and company insiders.
- Celldex Therapeutics Inc. shares outstanding for the quarter ending March 31, 2026 was 0.07 B shs, a 0.28% increase year-over-year.
- Celldex Therapeutics Inc. annual shares outstanding for 2025 was 0.07 B shs, a 3.15% increase from 2024.
- Celldex Therapeutics Inc. annual shares outstanding for 2024 was 0.06 B shs, a 32.91% increase from 2023.
- Celldex Therapeutics Inc. annual shares outstanding for 2023 was 0.05 B shs, a 3.33% increase from 2022.
- Celldex Therapeutics Inc. annual shares outstanding for 2022 was 0.05 B shs.
Shares Outstanding
ANNUAL · B SHS
QUARTERLY · B SHS
YEAR-OVER-YEAR GROWTH · %
Celldex Therapeutics Inc. Shares Outstanding — FAQ
Celldex Therapeutics Inc. (CLDX) shares outstanding over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
What is Celldex Therapeutics Inc.'s shares outstanding?
Celldex Therapeutics Inc. (CLDX) reported shares outstanding of 0.07B shares for fiscal 2025.
Where can I see CLDX's shares outstanding history?
The chart and table above show Celldex Therapeutics Inc.'s shares outstanding by year and by quarter, including the growth rate.